ABEONA THERAPEUTICS INC. 8-K

What Happened

• Abeona Therapeutics, Inc. (ABEO) announced its financial results for the year ended December 31, 2025 by issuing a press release on March 17, 2026. The press release reporting the company’s results was filed as Exhibit 99.1 to the Current Report on Form 8‑K and is incorporated by reference into the filing. This disclosure was made under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date of the 8‑K / press release: March 17, 2026.
• Reporting period covered: year ended December 31, 2025.
• Press release attached as Exhibit 99.1 to the Form 8‑K (and included Interactive XBRL cover page as Exhibit 104).
• The 8‑K is limited to results of operations/financial condition; no other Form 8‑K items (e.g., executive changes or mergers) were reported in this filing.

Why It Matters

• This is an earnings‑related disclosure: investors should review the press release for key figures such as revenue, net income/loss, cash and liquidity, and any management commentary or guidance that could affect the company’s outlook.
• Because the full text of the press release is incorporated into the 8‑K, it is the authoritative source for Abeona’s reported 2025 financial performance; shareholders and prospective investors should read Exhibit 99.1 for the detailed numbers and context before making decisions.